Aitiologic
A precision-medicine company developing liquid-biopsy tests that interpret cell-free DNA signals for early disease risk assessment.
€6.4MSeed
ParticipantActivity from announced rounds
A precision-medicine company developing liquid-biopsy tests that interpret cell-free DNA signals for early disease risk assessment.